82585-90-8

Basic information

• Product Name: (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester
• Synonyms: (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester;NSC 269416
• CAS NO: 82585-90-8
• Molecular Formula: C₁₉H₂₄N₆O₃
• Molecular Weight: 0
• Mol File: 82585-90-8.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 572.2°C at 760 mmHg
• Flash Point: 299.9°C
• Appearance: /
• Density: 1.34g/cm³
• Vapor Pressure: 4.2E-13mmHg at 25°C
• Refractive Index: 1.642
• CAS DataBase Reference: (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester(82585-90-8)
• EPA Substance Registry System: (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester(82585-90-8)

Safety Data

• Hazardous Substances Data: 82585-90-8(Hazardous Substances Data)

Usage

General Description

The chemical "5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester" is a compound with a complex molecular structure that includes an amino group, a dihydropyrido ring system, a carbamic acid moiety, and an ethyl ester functional group. (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester has potential applications in pharmaceuticals or drug development due to its structural features and functional groups which can interact with biological targets. The presence of the amino group and the pyrido ring system suggests that this compound may have potential biological activity, while the carbamic acid and ethyl ester groups can confer specific chemical properties such as solubility or bioavailability. Further research and investigation are necessary to determine the specific uses and potential effects of this compound.

InChI:InChI=1/C19H24N6O3/c1-4-28-19(26)24-16-9-15-17(18(20)23-16)22-12(10-21-15)11-25(2)13-5-7-14(27-3)8-6-13/h5-9,21H,4,10-11H2,1-3H3,(H3,20,23,24,26)

Upstream product

• 82585-58-8 (6-Amino-4-{2-[(E)-hydroxyimino]-3-[(4-methoxy-phenyl)-methyl-amino]-propylamino}-5-nitro-pyridin-2-yl)-carbamic acid ethyl ester 
• 6506-86-1 ethyl (6-amino-4-chloro-5-nitropyridin-2-yl)carbamate 
• 82740-35-0 1-Amino-3-[(4-methoxy-phenyl)-methyl-amino]-propan-2-one oxime 
• 82585-46-4 2-{2-[(E)-Hydroxyimino]-3-[(4-methoxy-phenyl)-methyl-amino]-propyl}-isoindole-1,3-dione 

Relevant articles and documents

1,2-dihydropyrido[3,4-b]pyrazines

1,2-Dihydropyrido[3,4-b]pyrazines are provided which possess anticancer activity. The compounds have the structure: STR1 wherein Y is CH2 or N(CH3); R1 is a lower alkyl group; e.g., an alkyl group containing up to six carb